Xinguang Pharmaceutical: Shareholders and Feng Investment plan to reduce their shareholding by no more than 3%.

New Light Pharmaceutical Industry announced that its shareholder Shengzhou City Hefeng Investment Co., Ltd., holding 15.74% of the shares, plans to reduce its holdings by no more than 1.6 million shares through centralized bidding and no more than 3.2 million shares through block trading within 3 months from the date of this announcement, namely from November 28, 2025 to February 27, 2026. The total reduction will not exceed 4.8 million shares, with the source of shares being those obtained before the IPO and from capital reserves, and the reduction price will be determined based on the market price at that time.